Clyde Yancy, MD

All posts by Clyde Yancy, MD

RSS

September 29th, 2014

The Implications of PARADIGM-HF for Clinical Practice

and

Clyde Yancy and Mary Norine Walsh offer their perspectives on the much-discussed PARADIGM-HF trial.


April 9th, 2014

Putting TOPCAT in Perspective

, and

TOPCAT investigators Bertram Pitt and Marc Pfeffer discuss the trial, and Clyde Yancy offers his analysis.


September 3rd, 2013

For CRT, Let ECG — Not Echo — Be Your Guide

and

Clyde Yancy, coauthor of the NEJM editorial about the EchoCRT Study Group’s randomized trial of echocardiography-guided CRT, provides further insights about the findings.


August 5th, 2013

Putting the 2013 Heart Failure Guidelines Into Practice

, and

CardioExchange’s Harlan Krumholz and John Ryan interview Clyde W. Yancy, lead member of the ACCF/AHA task force that wrote the 2013 guidelines for management of heart failure. Krumholz and Ryan: What is the biggest challenge to implementing the heart failure guidelines for every patient with heart failure? Yancy: The biggest challenge is no longer in establishing “proof.” […]


November 1st, 2010

AHA Preview: What Is Clyde Yancy Looking Forward to Seeing?

In the first installment of our AHA Preview series, we ask Clyde Yancy, medical director of the Baylor Heart and Vascular Institute and chief of Cardiothoracic Transplantation at Baylor University Medical Center, to list the trials in his field that he is most looking forward to at the AHA Scientific Sessions 2010 meeting.  See what […]